Open AccessPigmented basal cell carcinoma successfully treated with 5% imiquimod cream
Author(s) -
Vandana Mehta,
C Balachandran
Publication year - 2008
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/0019-5154.43204
Subject(s) - imiquimod , medicine , basal cell carcinoma , dermatology , basal cell , carcinoma , pathology
Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream.